T-cell large granular lymphocytic (T-LGL) leukemia: A single institution experience

Medical Oncology

Volumn 27, Issue 2, 2010, Pages 286-290

  Sretenovic, Aleksandra ^a   Antic, Darko ^a   Jankovic, Snezana ^a   Gotic, Mirjana ^a   Perunicic Jovanovic, Maja ^a   Jakovic, Ljubomir ^a   Mihaljevic, Biljana ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Chemotherapy; Clinical data; Large granular lymphocytic leukemia; T cell leukemia; T LGL leukemia

Indexed keywords

ALEMTUZUMAB; ANTINUCLEAR ANTIBODY; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUDARABINE; LACTATE DEHYDROGENASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE; RHEUMATOID FACTOR; T LYMPHOCYTE RECEPTOR; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CLINICAL ARTICLE; FATALITY; FEMALE; HEMOLYTIC ANEMIA; HEPATOMEGALY; HUMAN; HYPERGAMMAGLOBULINEMIA; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOGLOBULIN DEFICIENCY; LACTATE DEHYDROGENASE BLOOD LEVEL; LARGE GRANULAR LYMPHOCYTE LEUKEMIA; LYMPHADENOPATHY; LYMPHOCYTOSIS; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PURE RED CELL ANEMIA; RHEUMATOID ARTHRITIS; SPLENOMEGALY; T CELL LEUKEMIA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, LARGE GRANULAR LYMPHOCYTIC; MALE; MIDDLE AGED; PREDNISONE; VIDARABINE; VINCRISTINE;

EID: 77956942594     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9206-z     Document Type: Article

References (22)

1. Chan WC, Catovsky D, Foucar K, Montserrat E. T-cell large granular lymphocyte leukaemia. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. Pathology and genetics of tumours of hepatopoietic and lymphoid tissues. IARC: Lyon; 2001. p. 197-8.
2. Aribi A, et al. Experience in a single institution over 8 years. Leuk Res. 2007;31:939-45. doi:10.1016/j.leukres.2006.09.003. (Pubitemid 46856719)
3. Perzova R, Loughran TP Jr. Constitutive expression of Fas ligand in large granular lymphocyte leukaemia. Br J Haematol. 1997;97:123-6. doi:10.1046/j.1365-2141.1997.d01-2113.x.
4. Oshimi K, Shinkai Y, Okumura K, Oshimi Y, Mizoguchi H. Perforin gene expression in granular lymphocyte proliferative disorders. Blood. 1990;75:704-8.
5. Kothapalli R, et al. Constitutive expression of cytotoxic proteases and down regulation of protease inhibitors in LGL leukemia. Int J Oncol. 2003;22:33-9.
6. Loughran TP Jr, et al. Detection of human T cell leukemia/ lymphoma virus, type II, in a patient with large granular lymphocyte leukemia. Blood. 1992;80:1116-9.
7. Loughran TP Jr, et al. Epitope mapping of HTLV envelope seroreactivity in LGL leukaemia. Br J Haematol. 1998;101:318-24. doi:10.1046/j.1365-2141.1998. 00691.x. (Pubitemid 28261120)
8. Greer JP, Kinney MC, Loughran Jr TP. T cell and NK cell lymphoproliferative disorders. Hematology Am Soc Hematol Educ Program 2001; 259-81. doi:10.1182/asheducation-2001.1.259.
9. Sokol L, Loughran TP Jr. Large granular lymphocyte leukemia. Oncologist. 2006;11:263-73. doi:10.1634/theoncologist.11-3-263.
10. Dhodapkar M, Chin-Yang L, Lust J, Tefferi A, Phyliky RL. Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance? Blood. 1994;84:1620-7.
11. Loughran TP Jr, Kidd PG, Starkebaum G. Treatment of large granular lymphocyte leukemia with oral low-dose methotrexate. Blood. 1994;84:2164-70.
12. Osuji N, et al. T-cell large granular lymphocyte leukemia: a report on the treatment of 29 patients and a review of the literature.Cancer. 2006;107:570-8. doi:10.1002/cncr.22032. (Pubitemid 44107218)
13. Tse E, et al. Fludarabine, mitoxantrone and dexamethasone as firstline treatment for T-cell large granular lymphocyte leukemia. Leukaemia. 2007;21(10):2225-6. doi:10.1038/sj.leu.2404767. (Pubitemid 47423825)
14. Kwong YL, Wong KF. Association of pure red cell aplasia with T large granular lymphocyte leukaemia. J Clin Pathol. 1998;51: 672-5. doi:10.1136/jcp.51.9.672.
15. Sternberg A, et al. Neutropenia and anaemia associated with T-cell large granular lymphocyte leukaemia responds to fludarabine with minimal toxicity. Br J Haematol. 2003;120:699-701. doi:10.1046/j.1365-2141.2003.04148.x. (Pubitemid 36255874)
16. Ru X, Leibman HA. Successful treatment of refractory pure red cell aplasia associated with lymphoproliferative disorders with the anti-CD52 monoclonal antibody alemtuzumab (Campath-1H). Br J Haematol. 2003;123:278-81. doi:10.1046/j.1365-2141.2003. 04609.x.
17. Rosenblum MD, et al. Efficacy of alemtuzumab treatment for refractory T-cell large granular lymphocytic leukaemia. Blood. 2004;103:1969-71. doi:10.1182/blood-2003-11-3951. (Pubitemid 38269004)
18. Osuji N. CD52 expression in T-cell large granular lymphocyte leukaemia-implications for treatment with alemtuzumab. Leuk Lymphoma. 2005;46:723-7. doi:10.1080/10428190500052156. (Pubitemid 40775221)
19. Ruskova A, Thula R, Chan G. Aggressive natural killer-cell leukemia: report of five cases and review of the literature. Leuk Lymphoma. 2004;45:2427-38. doi:10.1080/10428190400004513. (Pubitemid 40081185)
20. Battiwalla M, et al. HLA-DR4 predicts haematological response to cyclosporine in T-large granular lymphocyte lymphoproliferative disorders. Br J Haematol. 2003;123:449-53. doi: 10.1046/j.1365-2141.2003.04613.x. (Pubitemid 37363485)
21. Matrai Z, Lelkes G, Milosevits J, Paldine HP, Pecze K. T-cell large granular lymphocytic leukemia associated with pure red cell aplasia, successfully treated with cyclophosphamide. Orv Hetil. 1997;138:2075-80. (Hungarian).
22. Langford CA, Klippel JH, Balow JE, James SP, Sneller MC. Use of cytotoxic agents and cyclosporine in the treatment of autoimmune disease. Part 2. Inflammatory bowel disease and systemic vasculitis, and therapeutic toxicity. Ann Intern Med. 1998;129:49-58.